Oragenics OGEN
Oragenics Regains Full NYSE American Compliance
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001493152-25-018725
- Signs a material agreement (1.01)
- Reports an exchange listing deficiency notice (3.01)
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- MetaVia MTVA public float $3M, Jun 30, 2025
- Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
- PTC Therapeutics PTCT public float $3M, Jun 30, 2025
- Integrated Biopharma INBP public float $3M, Dec 31, 2025
- Enveric Biosciences ENVB public float $4M, Jun 30, 2025